Can a blood test predict Chemo's toll on fertility?
NCT ID NCT03731845
Summary
This study aims to understand why some young women treated for breast cancer experience more severe fertility loss after chemotherapy than others. Researchers will follow 73 young women to see if specific genetic markers, linked to the age of natural menopause, can predict who is most at risk for reduced ovarian function. The goal is to help doctors better counsel patients about fertility preservation options before treatment begins.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Antoine Béclère Hospital
Clamart, 92140, France
Conditions
Explore the condition pages connected to this study.